Strengthening Clinical Operations Through Innovation
Medidata, a leading provider of clinical trial solutions under Dassault Systèmes, is expanding its collaboration with the National Cancer Institute (NCI). This strategic partnership aims to enhance the continuity of medical and clinical data for various Lead Protocol Organizations (LPOs). Medidata's solutions introduce new efficiencies and reduce the complexities involved in managing clinical trials.
Introducing Advanced Solutions for Efficiency
The solutions at the heart of this collaboration are the Medidata Health Record Connect and Medidata Rave Companion. These tools automatically integrate patient data from electronic health records (EHRs) into the Medidata Platform. This innovative approach alleviates administrative burdens and allows research sites to concentrate more on delivering patient care.
Transforming Data Management for Clinical Trials
Wayne Walker, the senior vice president for Data Experience at Medidata, expressed that the ongoing challenge in using EHRs within clinical studies is being addressed effectively through these new enhancements. With these tools, research sites can significantly decrease repetitive tasks, thereby facilitating easier patient participation and improving the overall quality and speed of data collection.
A Unique Solution for NCI Lead Protocol Organizations
By enabling the collection of data up to 90% faster, Medidata's solutions empower NCI LPOs to perform their functions with unprecedented efficiency. This capability is vital for the development and evaluation of new therapies, allowing researchers to progress from initial safety trials to comprehensive randomized controlled trials seamlessly.
Longstanding Partnership Focused on Future Innovations
Medidata has collaborated with the NCI Cancer Therapy Evaluation Program (CTEP) for many years, providing essential tools that strengthen their clinical operations. This partnership has facilitated the exploration of over 36,000 clinical trials on more than 11 million patients, showcasing Medidata's extensive expertise in the field.
Enhancing Patient Experience and Accelerating Breakthroughs
Celebrating 25 years in the industry, Medidata continues to push the boundaries of innovation in clinical trials. With one of the largest clinical trial data sets available, the company has streamlined processes that lead to better patient outcomes. By introducing advanced digital solutions, Medidata is not only improving patient experiences but also expediting the journey from research to market for novel therapies.
About Medidata and Dassault Systèmes
As part of Dassault Systèmes, Medidata's mission is to enable smarter healthcare solutions that drive human progress. Established as a pioneer in digital innovations, the company has a profound impact on improving health outcomes worldwide. With strong credentials that include recognition from reputable industry leaders, Medidata positions itself as an advocate for both researchers and patients.
Frequently Asked Questions
What is the purpose of the Medidata and NCI partnership?
The partnership aims to improve the management and continuity of clinical data in research, enhancing the efficiency of clinical trials through innovative technological solutions.
How do Health Record Connect and Rave Companion help?
These tools automate the integration of EHR data into the clinical trial processes, significantly reducing administrative tasks and allowing for faster data collection and patient care focus.
How long has Medidata been working with NCI?
Medidata has collaborated with the National Cancer Institute for over 17 years, providing continuous support and technological innovations to enhance clinical operations.
What kind of clinical trials does Medidata support?
Medidata supports a wide range of clinical trials across various therapeutic areas, focusing on innovative solutions to improve trial outcomes and patient experiences.
Where is Medidata headquartered?
Medidata is headquartered in New York City, where it continues to lead in developing digital healthcare solutions for clinical trials.
